All In MedTech

Company

Staar Surgical

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

STAA

Nasdaq · STAAR SURGICAL CO

Public float

$884M

Value of shares held by non-insiders on Jun 27, 2025

Revenue

$239M

Fiscal year ending Jan 2, 2026

Net income

-$80.4M

Fiscal year ending Jan 2, 2026

R&D spending

$40.1M

Fiscal year ending Jan 2, 2026

Cash

$134M

As of Oct 2, 2026

Long-term debt

Not reported

Shares outstanding

50.2M

As of Oct 30, 2026

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is free with an account

For Staar Surgical we have 4 shareholders with 5% or more.

Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

Latest FDA decisions

Search the Clearance Tracker

3 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07791381 · 10 participants (planned) · Start Nov 2026 · Primary completion May 2027

    Device: Implantable collamer lens (ICL) · For: Myopia; Astigmatism

6 more trials with a free account

Reports received

2,524

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

60

2.4% of reports

Injury reports

2,464

98% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2310834700
Jan 249531600
Feb 2411334900
Mar 2411340500
Apr 2413541700
May 2413131900
Jun 248930100
Jul 249738600
Aug 248752700
Sep 247943400
Oct 249138300
Nov 248033900
Dec 245142300
Jan 25117100
Feb 25012800
Mar 25015400
Apr 25015100
May 25011100
Jun 25014700
Jul 25016800
Aug 25019700
Sep 25018700
Oct 25022300
Nov 25017900
Dec 25023500
Jan 26013300
Feb 26119500
Mar 26019400
Apr 26320700
May 26518100
Jun 26326000
Jul 263022300
Aug 261722600
Sep 26122800
Oct 26020300
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

The full in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

23 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.